Code | 5843D | ||||||||||
MA number | 15/0239/20-S | ||||||||||
Product Form: | plo ijf 50x2 g (liek.inj.skl.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intramuscular or intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 27.11.2020 |
Validity: | 27.11.2025 |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Flucloxacillin Fresenius Kabi 1 g a 2 g plo ijf_05.2023.pdf |
SPC: | SPC_Flucloxacillin Fresenius Kabi 1 g a 2 g plo ijf_05.2023.pdf |
Safety feature | Yes |
Data update: | 01.12.2020 |